# Marker Therapeutics (MRKR.US)

Canonical: https://gigainvestors.com/s/MRKR

Analysis as of: 2026-10-16T07:30:22.463Z. 

Listing currency: USD. Reporting currency: USD.

## Verdict

Not enough history yet

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $0.92 per share; close as of 2026-10-15.

## Checklist

### understandable: na

### moat: na

### economics: na

### management: na

### accounting: na

## Holders

## Price story

Down 84% since Aug 2023

Story as of 2026-10-16T10:01:29.734Z; price observation 2026-10-15.

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### Where the cash goes

Paid no dividends in 3 years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-18); Dividend observations: [[2021,0],[2022,0],[2023,0]]. Zero only counted when supported by a complete cash-flow statement.

### What the price says

The price is 0.8 times net assets.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-18); Closing price 0.92 USD; reporting-to-trading FX 1; FY2025 net assets per share 1.0970918416533488; price multiple 0.8385806594036227. FY2023 cash earnings/share -1.963614473750826. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2016-10: $5.00 per share

- 2016-11: $4.54 per share

- 2016-12: $3.88 per share

- 2017-01: $4.18 per share

- 2017-02: $4.51 per share

- 2017-03: $4.49 per share

- 2017-04: $4.20 per share

- 2017-05: $3.90 per share

- 2017-06: $3.88 per share

- 2017-07: $3.25 per share

- 2017-08: $3.25 per share

- 2017-09: $3.01 per share

- 2017-10: $3.02 per share

- 2017-11: $2.78 per share

- 2017-12: $3.92 per share

- 2018-01: $3.90 per share

- 2018-02: $3.25 per share

- 2018-03: $3.38 per share

- 2018-04: $2.65 per share

- 2018-05: $5.16 per share

- 2018-06: $9.43 per share

- 2018-07: $7.01 per share

- 2018-08: $8.62 per share

- 2018-09: $9.05 per share

- 2018-10: $9.02 per share

- 2018-11: $7.06 per share

- 2018-12: $5.55 per share

- 2019-01: $5.29 per share

- 2019-02: $6.22 per share

- 2019-03: $6.60 per share

- 2019-04: $5.28 per share

- 2019-05: $5.61 per share

- 2019-06: $7.92 per share

- 2019-07: $4.61 per share

- 2019-08: $5.17 per share

- 2019-09: $5.11 per share

- 2019-10: $3.84 per share

- 2019-11: $3.34 per share

- 2019-12: $2.88 per share

- 2020-01: $2.59 per share

- 2020-02: $2.47 per share

- 2020-03: $1.90 per share

- 2020-04: $2.76 per share

- 2020-05: $2.27 per share

- 2020-06: $2.07 per share

- 2020-07: $2.01 per share

- 2020-08: $1.80 per share

- 2020-09: $1.50 per share

- 2020-10: $1.36 per share

- 2020-11: $1.70 per share

- 2020-12: $1.45 per share

- 2021-01: $1.92 per share

- 2021-02: $2.42 per share

- 2021-03: $2.24 per share

- 2021-04: $2.56 per share

- 2021-05: $2.91 per share

- 2021-06: $2.79 per share

- 2021-07: $2.09 per share

- 2021-08: $1.98 per share

- 2021-09: $1.69 per share

- 2021-10: $1.47 per share

- 2021-11: $1.18 per share

- 2021-12: $0.95 per share

- 2022-01: $0.61 per share

- 2022-02: $0.38 per share

- 2022-03: $0.44 per share

- 2022-04: $0.34 per share

- 2022-05: $0.30 per share

- 2022-06: $0.33 per share

- 2022-07: $0.32 per share

- 2022-08: $0.31 per share

- 2022-09: $0.37 per share

- 2022-10: $0.44 per share

- 2022-11: $0.30 per share

- 2022-12: $0.27 per share

- 2023-01: $2.80 per share

- 2023-02: $2.17 per share

- 2023-03: $0.71 per share

- 2023-04: $0.84 per share

- 2023-05: $1.78 per share

- 2023-06: $3.10 per share

- 2023-07: $5.05 per share

- 2023-08: $5.62 per share

- 2023-09: $4.54 per share

- 2023-10: $2.40 per share

- 2023-11: $2.76 per share

- 2023-12: $5.50 per share

- 2024-01: $4.64 per share

- 2024-02: $3.63 per share

- 2024-03: $4.30 per share

- 2024-04: $4.05 per share

- 2024-05: $3.87 per share

- 2024-06: $5.43 per share

- 2024-07: $4.89 per share

- 2024-08: $3.61 per share

- 2024-09: $2.82 per share

- 2024-10: $4.05 per share

- 2024-11: $3.50 per share

- 2024-12: $3.11 per share

- 2025-01: $1.84 per share

- 2025-02: $1.53 per share

- 2025-03: $1.23 per share

- 2025-04: $1.19 per share

- 2025-05: $1.56 per share

- 2025-06: $1.53 per share

- 2025-07: $1.40 per share

- 2025-08: $0.93 per share

- 2025-09: $0.89 per share

- 2025-10: $0.99 per share

- 2025-11: $1.24 per share

- 2025-12: $1.49 per share

- 2026-01: $1.60 per share

- 2026-02: $1.48 per share

- 2026-03: $1.30 per share

- 2026-04: $1.46 per share

- 2026-05: $1.57 per share

- 2026-06: $1.47 per share

- 2026-07: $1.13 per share

- 2026-08: $1.33 per share

- 2026-09: $1.07 per share

- 2026-10: $0.92 per share

## Annual estimated value (USD per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/1094038/000110465926031274/mrkr-20251231x10k.htm); period 2025-12-31, filed 2026-03-18.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.
← Companies

Marker Therapeutics

MRKR · US

Financial history

5 annual periods on record.

The business

Where the cash goes
What the price says
Revenue / share$0
Owner earnings / share-$1.96
Tangible book / share$1.10
Book value / share$1.10